Pulmonx Corporation (NASDAQ: LUNG) reported Q3 EPS of ($0.34), $0.08 better than the analyst estimate of ($0.42). Revenue for the quarter came in at $21.5 million versus the consensus estimate of $20.78 million.

For earnings history and earnings-related data on Pulmonx Corporation (LUNG) click here.